XWELL, Inc. (XWEL)
0.494
-0.08
(-13.35%)
USD |
NASDAQ |
Dec 30, 15:10
XWELL EPS Diluted (Quarterly): -0.2557 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| FONAR Corp. | 0.3368 |
| ProPhase Labs, Inc. | -1.646 |
| Veracyte, Inc. | 0.2401 |
| Insight Molecular Diagnostics, Inc. | -0.3388 |
| Exagen, Inc. | -0.3089 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.211M |
| Revenue (Quarterly) | 7.345M |
| Total Expenses (Quarterly) | 8.069M |
| Enterprise Value | 18.35M |
| Gross Profit Margin (Quarterly) | 17.32% |
| Profit Margin (Quarterly) | -2.87% |
| Earnings Yield | -639.2% |
| Normalized Earnings Yield | -626.15 |